Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib

Clin Lymphoma Myeloma. 2007 Mar;7(5):376-8. doi: 10.3816/CLM.2007.n.017.

Abstract

Intracranial multiple myeloma is uncommon. Cavernous sinus involvement has rarely been reported, generally associated with treatment-refractory disease and poor outcome. We report clinical data and neuroradiologic findings of 3 patients with multiple myeloma and unilateral cavernous sinus involvement. At neuroradiology, this resulted from diffuse bone involvement as disease relapse (n=2) or focal dural disease (n=1) as the presenting sign. Interestingly, bortezomib treatment resulted in complete clinical resolution in 1 patient and partial clinical and significant magnetic resonance response in another, whereas in the literature, local radiation therapy has been reported as the only efficient treatment.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Cavernous Sinus / pathology*
  • Fatal Outcome
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Pyrazines / therapeutic use*
  • Recurrence
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib